I recently had a CT scan, and my score was 184. My cardiologist put me on 40 mg of Lipitor, which I reluctantly took for ...

First quarter 2025 total revenues increased 4% to $149.8 million, compared to the same period in 2024. First quarter 2025 total revenues excluding Trokendi XR ® and Oxtellar XR ® net sales (non-GAAP) ...

Weekend warriors to elite athletes hail the benefits of cold water immersion, but the research is yet to support its claimed benefits.

Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule ...

Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to omalizumab experienced ...

There you are — in bed with your partner, panting, sweaty and ready for round two. Your brain is cocked and ready to rock, ...

Dr. Peter Hotez, Co-director of the Texas Children’s Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine at Baylor College of Medicine, joins "Forbes Newsroom" ...

Initiate Hold rating on Tonix Pharmaceuticals due to increased approval odds for TNX-102 SL but concerns over commercial ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Secretary Robert F. Kennedy Jr pledged last week that his department will now require all new vaccines to be tested in ...

The HHS will begin to require placebo-controlled trials for all new vaccines, which will radically alter the testing process.